News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
China Resources Pharmaceutical (03320.HK) Subsidiarys Category 3 Anti-rejection Generic Drug Approved for Production
China Resources Pharmaceutical (03320.HK) announced that its subsidiary Kunming Baker Norton has obtained production approval for its Category 3 generic drug, Mycophenolate Mofetil...
Reset
Send
The window will close in 5 seconds
China Resources Pharmaceutical (03320.HK) Subsidiarys Category 3 Anti-rejection Generic Drug Approved for Production
Close
Recommend
6
Positive
2
Negative
3
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

China Resources Pharmaceutical (03320.HK)  +0.050 (+1.082%)    Short selling $3.78M; Ratio 6.002%   announced that its subsidiary Kunming Baker Norton has obtained production approval for its Category 3 generic drug, Mycophenolate Mofetil for Suspension, which is deemed to have passed the consistency evaluation.

According to the company, Mycophenolate Mofetil for Suspension is classified as a Category B drug under the National Reimbursement Drug List. It is indicated for the prevention of organ rejection in patients receiving allogeneic kidney or liver transplants, and can also be used for induction and maintenance therapy in patients with lupus nephritis. (hc/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-29 16:25.)

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.